Discontinuation report ACT ROSUVASTATIN
Report ID | 65325 |
Drug Identification Number | 02339781 |
Brand name | ACT ROSUVASTATIN |
Common or Proper name | ROSUVASTATIN |
Company Name | ACTAVIS PHARMA COMPANY |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ROSUVASTATIN |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-07-31 |
Remaining supply date | 2018-07-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Transitioned. TEVA available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2018-10-22 | French | Compare |
v1 | 2018-10-22 | English | Compare |
Showing 1 to 2 of 2